Patient Guide: Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 12 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT03909334
Status: ACTIVE_NOT_RECRUITING
Condition: Non Small Cell Lung Cancer, EGFR Gene Mutation, Advanced Cancer, Metastatic Cancer
Phase: PHASE2

Find a Study Location Near You

This study is available at 12 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Washington D.C., District of Columbia
  • Tampa, Florida
  • Chicago, Illinois
  • • And 9 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily